Benzinga | Aug 10, 2020 09:12AM EDT

Intercept Pharmaceuticals Sees FY2020 Sales $300.000M-320.000M vs $288.07M Est

Intercept Pharmaceuticals (NASDAQ:ICPT) sees FY2020 sales of $300.000 million-320.000 million vs $288.07 million estimate.